Clinical characteristics and presence of prolactinoma in women with hyperprolactinemia

被引:0
|
作者
Alberto Lopez-Clavijo, Carlos [1 ,2 ,3 ,4 ]
Esteban Gaviria-Maya, Juan [5 ]
Eduardo Henao-Florez, Rodrigo [2 ]
Leandro Piedrahita-Gutierrez, Dany [3 ,6 ]
机构
[1] InSer Pereira, Pereira, Colombia
[2] Univ Caldas, Ginecol & Obstet, Manizales, Colombia
[3] Fdn Univ Autonoma Amer, Medellin, Colombia
[4] Univ Tecnol Pereira, Biol Mol & Biotecnol, Pereira, Colombia
[5] Univ Caldas, Manizales, Colombia
[6] InSer Pereira, Endocrinol Reprod Humana & Infertilidad, Pereira, Colombia
关键词
Amenorrhea; Galactorrhea; Hyperprolactinemia; Infertility; Magnetic Resonance Imaging; Prolactin; Prolactinoma;
D O I
10.17533/udea.iatreia.v29n3a04
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To clinically characterize women with hyperprolactinemia at InSer Pereira (Colombia) and to determine the prevalence of prolactinoma. Methods: Retrospective description of 45 patients with hyperprolactinemia, and contrasted pituitary magnetic resonance (MR), between January 2008 and July 2013. Clinical manifestations, etiology, serum prolactin level, and MR findings were included. Results: The most frequent clinical manifestations were: infertility, galactorrhea, oligomenorrhea. There were 26 cases of prolactinoma (57.8 %), and 12 of idiopathic hyperprolactinemia (26.6 %). Out of the 26 prolactinomas, 23 were microadenomas (average size 5.1 mm; SD +/- 3.2 mm). Average serum prolactin level was 74.05 ng/mL (SD +/- 13.33 ng/mL). 78 % of patients with prolactinoma had serum prolactin level under 70.0 ng/mL. No significant association was found between serum prolactin level and the presence of prolactinoma. Conclusion: Prolactinomas are the main cause of hyperprolactinemia and they are found mostly with slight rise of serum prolactin. Pituitary MRI is recommended in patients with hyperprolactinemia, regardless of their prolactin level.
引用
收藏
页码:292 / 300
页数:9
相关论文
共 50 条
  • [31] Nutritional and metabolic assessment in overweight patients with and without hyperprolactinemia caused by prolactinoma
    de Freitas, Bruna Breyer
    Rothen, Renata Elisabeth
    Zeni, Debora
    Soares Leaes, Carolina Garcia
    Oliveira, Miriam da Costa
    Busnello, Fernanda Michielin
    Semmelmann Pereira-Lima, Julia Fernando
    NUTRICION HOSPITALARIA, 2015, 32 (05) : 2030 - 2037
  • [32] Resolution of Hyperprolactinemia with Bromocriptine in Two Patients with Cabergoline Resistant Prolactinoma.
    Iyer, P.
    Molitch, M. E.
    ENDOCRINE REVIEWS, 2010, 31 (03)
  • [33] Hyperprolactinemia in women: treatment
    Benetti-Pinto, Cristina Laguna
    Nacul, Andrea Prestes
    Rosa e Silva, Ana Carolina Japur
    Maciel, Gustavo Arantes Rosa
    Nogueira, Vania dos Santos Nunes
    Elias, Paula Conde Lamparelli
    Martins, Manoel
    Kasuki, Leandro
    Garmes, Heraldo Mendes
    Glezer, Andrea
    REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2024, 46
  • [34] Metoclopramide Stimulation Test can Rule Out Prolactinoma in Patients with Moderate Hyperprolactinemia
    Gonzalez, A.
    Moreno, A.
    Deza, S.
    Salvador, J.
    Galofre, J. C.
    Alegre, E.
    CLINICAL CHEMISTRY, 2024, 70
  • [35] Pregnancy and Tumor Outcomes in Women with Prolactinoma: Prolactinoma and Pregnancy: Outcomes
    Araujo, Barbara
    Belo, Sandra
    Carvalho, Davide
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2017, 125 (10) : 642 - 648
  • [36] Clinical and Radiographic Characteristics Related to Hyperprolactinemia in Nonfunctioning Pituitary Adenomas
    Park, Seung Shin
    Kim, Jung Hee
    Kim, Yong Hwy
    Lee, Jung Hyun
    Dho, Yun-Sik
    Shin, Chan Soo
    WORLD NEUROSURGERY, 2018, 119 : E1035 - E1040
  • [37] Clinical and Laboratory Characteristics of Hyperprolactinemia in Children and Adolescents: National Survey
    Eren, Erdal
    Ergur, Ayca Torel
    Isguven, Sukriye Pinar
    Bitkin, Eda Celebi
    Berberoglu, Merih
    Siklar, Zeynep
    Bas, Firdevs
    Yel, Servet
    Bas, Serpil
    Sobu, Elif
    Bereket, Abdullah
    Turan, Serap
    Saglam, Halil
    Atay, Zeynep
    Ercan, Oya
    Guran, Tulay
    Atabek, Mehmet Emre
    Korkmaz, Huseyin Anil
    Ugurlu, Aylin Kilinc
    Akinci, Aysehan
    Doger, Esra
    Simsek, Enver
    Akbas, Emine Demet
    Abaci, Ayhan
    Gul, Ulku
    Acar, Sezer
    Ucakturk, Eda Mengen
    Yildiz, Melek
    Unal, Edip
    Tarim, Omer
    JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY, 2019, 11 (02) : 149 - 156
  • [38] Does DRD2 polymorphism influence the clinical characteristics of prolactinoma?
    Ilhan, Muzaffer
    Kahraman, Ozlem Timirci
    Turan, Saime
    Turgut, Seda
    Karaman, Ozcan
    Zeybek, Umit
    Shukurov, Samir
    Yaylim, Ilhan
    Tasan, Ertugrul
    ANNALES D ENDOCRINOLOGIE, 2015, 76 (05) : 614 - 619
  • [39] HYPERPROLACTINEMIA IN HEALTHY WOMEN
    LINDSTEDT, G
    LUNDBERG, PA
    BENGTSSON, C
    NYSTROM, E
    BJURSTAM, N
    LEMAN, J
    RYBO, G
    CLINICAL CHEMISTRY, 1984, 30 (01) : 165 - 166
  • [40] Hemoglobin decline as a signal for hyperprolactinemia onset prior to prolactinoma diagnosis in hypogonadal men
    Rudman, Yaron
    Duskin-Bitan, Hadar
    Richter, Ilan
    Tsvetov, Gloria
    Masri-Iraqi, Hiba
    Akirov, Amit
    Shimon, Ilan
    ANDROLOGY, 2023, : 1398 - 1407